Karen L. Bergman
Investor Relations Contact at BOLT BIOTHERAPEUTICS, INC.
Profile
Karen L.
Bergman is the founder of BCC Partners LLC.
She is currently the Vice President-Communications & Investor Relations at Bolt Biotherapeutics, Inc. Prior to this, she held the same position at ALZA Corp.
and was also the Vice President-Investor Relations & Communications at FibroGen, Inc. Ms. Bergman completed her undergraduate degree at Yale University.
Karen L. Bergman active positions
| Companies | Position | Start |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Investor Relations Contact | - |
Former positions of Karen L. Bergman
| Companies | Position | End |
|---|---|---|
| BCC Partners LLC | Founder | - |
| ALZA CORPORATION | Investor Relations Contact | - |
| FIBROGEN, INC. | Investor Relations Contact | - |
Training of Karen L. Bergman
| Yale University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| BOLT BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| BCC Partners LLC | |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
- Stock Market
- Insiders
- Karen L. Bergman